HLA-G and neoplasm: The in vivo experiments provided further evidence that engineering with HLA‐G‐targeted Nb‐CAR redirected γδT cells to tumor lesions and the secreted PD‐L1 Nb‐BiTE recruited T cells to infiltrate and accumulate in the local tumor foci.